BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CCND3, P30281, 896, ENSG00000112576 AND Prognosis
21 results:

  • 1. CT-based radiomics models may predict the early efficacy of microwave ablation in malignant lung tumors.
    Zhu F; Yang C; Xia Y; Wang J; Zou J; Zhao L; Zhao Z
    Cancer Imaging; 2023 Jun; 23(1):60. PubMed ID: 37308918
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations.
    Shimoda M; Tanaka Y; Morimoto K; Yoshimori K; Ohta K
    Intern Med; 2023 Dec; 62(24):3601-3607. PubMed ID: 37081679
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting diacylglycerol kinase α impairs lung tumorigenesis by inhibiting cyclin D3.
    Zhou D; Liu T; Rao X; Jie X; Chen Y; Wu Z; Deng H; Zhang D; Wang J; Wu G
    Thorac Cancer; 2023 May; 14(13):1179-1191. PubMed ID: 36965165
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A deep belief network-based clinical decision system for patients with osteosarcoma.
    Li W; Dong Y; Liu W; Tang Z; Sun C; Lowe S; Chen S; Bentley R; Zhou Q; Xu C; Li W; Wang B; Wang H; Dong S; Hu Z; Liu Q; Cai X; Feng X; Zhao W; Yin C
    Front Immunol; 2022; 13():1003347. PubMed ID: 36466868
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
    Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
    [No Abstract]    [Full Text] [Related]  

  • 6. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell lung cancer.
    He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
    Front Immunol; 2022; 13():835630. PubMed ID: 35401554
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A semi-supervised learning framework for micropapillary adenocarcinoma detection.
    Gao Y; Ding Y; Xiao W; Yao Z; Zhou X; Sui X; Zhao Y; Zheng Y
    Int J Comput Assist Radiol Surg; 2022 Apr; 17(4):639-648. PubMed ID: 35149953
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes.
    Luo X; Huang X; Liu S; Wang X; Luo J; Xiao J; Wang K; Qu Y; Chen X; Zhang Y; Wang J; Zhang J; Xu G; Gao L; Wu R; Yi J
    Cancer Med; 2022 Feb; 11(4):1059-1067. PubMed ID: 35080148
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Whole genomic copy number variation score: an indicator of potential diagnostic and prognostic value for lung adenocarcinoma].
    Zhang L; He L; Li SL; Du J; Di J; Yang L; Liu CL; Yin LY; Cheng Y; Gong YY; Wu W; Liu DG; Wang Z
    Zhonghua Zhong Liu Za Zhi; 2020 Jul; 42(7):543-550. PubMed ID: 32842440
    [No Abstract]    [Full Text] [Related]  

  • 10. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
    Yu J; Hu Y; Xu Y; Wang J; Kuang J; Zhang W; Shao J; Guo D; Wang Y
    BMC Cancer; 2019 Mar; 19(1):263. PubMed ID: 30902072
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non-Small-Cell lung cancer: FDG Uptake and Risk Stratification.
    Moon SH; Sun JM; Ahn JS; Park K; Ahn MJ; Choi JY
    Clin Nucl Med; 2019 Feb; 44(2):e60-e67. PubMed ID: 30516679
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.
    Hiraoka A; Otsuka Y; Kawasaki H; Izumoto H; Ueki H; Kitahata S; Aibiki T; Okudaira T; Yamago H; Miyamoto Y; Iwasaki R; Tomida H; Mori K; Miyata H; Tsubouchi E; Kishida M; Hirooka M; Abe M; Matsuura B; Ninomiya T; Mori I; Hiasa Y; Michitaka K
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1271-1276. PubMed ID: 29193248
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor prognosis and Promotes Clinical Progression and Metastasis in Bladder cancer.
    Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB
    Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer.
    Xu CH; Yang Y; Wang YC; Yan J; Qian LH
    Oncotarget; 2017 Apr; 8(14):22483-22489. PubMed ID: 28160556
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).
    Pastor MD; Nogal A; Molina-Pinelo S; Quintanal-Villalonga Á; Meléndez R; Ferrer I; Romero-Romero B; De Miguel MJ; López-Campos JL; Corral J; García-Carboner R; Carnero A; Paz-Ares L
    J Thorac Oncol; 2016 Dec; 11(12):2183-2192. PubMed ID: 27524264
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Outcomes after surgical resection of pulmonary carcinoid tumors.
    Okereke IC; Taber AM; Griffith RC; Ng TT
    J Cardiothorac Surg; 2016 Mar; 11():35. PubMed ID: 26935588
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
    Ma H; Chen J; Pan S; Dai J; Jin G; Hu Z; Shen H; Shu Y
    Lung Cancer; 2011 Jul; 73(1):32-7. PubMed ID: 21145615
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
    Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
    Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [The so-called malignant pleural effusion: a new review of direct data obtained with diagnostic pleuroscopy].
    Cantó A; Arnau A; Galbis J; Martín E; Guijarro R; Fernández A; Martínez P; Martorell M; Pareja E; García-Aguado R; Rico G
    Arch Bronconeumol; 1996 Nov; 32(9):453-8. PubMed ID: 9064083
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.